SynthesisCancer medicine2023

Risks of hypertension and thromboembolism in patients receiving bevacizumab with chemotherapy for colorectal cancer: A systematic review and meta-analysis.

Akshit Chitkara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.